Diphtheria
📧 Sign up to get email alerts when something new happens for Diphtheria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants [Phase 3]
This Phase 3 trial in healthy infants evaluated whether giving Tritanrix-HepB/Hib-MenAC with a birth-dose Hepatitis B vaccine yields an immu…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety [Phase 2]
Phase 2 trial comparing GSK's DTaP-IPV candidate vaccine with separately administered DTaP and IPV vaccines to assess immune response and sa…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine. [Phase 3]
Phase 3 results evaluating a GSK Tdap booster vaccine candidate for immunogenicity and safety in children and adolescents previously given f…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV) [Phase 4]
Phase 4 immunogenicity and reactogenicity study of Boostrix and Boostrix-IPV has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects. [Phase 2]
Phase 2 trial by GlaxoSmithKline evaluated antibody persistence and booster response, as well as safety, in individuals previously primed wi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine [Phase 3]
Phase 3 trial comparing a combined Tdap booster to a licensed Td vaccine has completed, assessing protection against diphtheria, tetanus, an…
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Comparison of GSK Biologicals' Reduced Antigen Diphtheria and Tetanus Toxoids and Acellular Pertussis- Inactivated Poliovirus Vaccine, to BoostrixTM and Inactivated Poliovirus Vaccine Administered Separately and With Revaxis® [Phase 3]
Phase 3 trial comparing GlaxoSmithKline's reduced antigen DTaP-IPV vaccine to Boostrix and standalone or Revaxis-administered IPV in tetanus…
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants [Phase 3]
Phase 3 trial evaluating the immunogenicity and reactogenicity of GSK DTPa-HBV-IPV and Hib vaccines when coadministered to healthy infants.
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines. [Phase 4]
This Phase 4 trial update evaluates immunogenicity, antibody persistence, and safety of GSK's DTPa INFANRIX and dTpa BOOSTRIX vaccines; the …
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine [Phase 3]
Phase 3 trial update evaluating the immunogenicity and reactogenicity of the DTPa-HBV-IPV/Hib vaccine given in a schedule with subsequent va…
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course [Phase 4]
Phase 4 trial comparing immunogenicity and reactogenicity of INFANRIX HEXA and INFANRIX HEXAVAC as a primary vaccination course; completed s…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers [Phase 3]
A Phase 3 trial comparing Pediacel to Infanrix-IPV+Hib when co-administered with Prevenar in infants and toddlers has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: Study of Adacel® Vaccine Administered to Persons 10 Years of Age [Phase 4]
Phase 4 clinical trial of the Adacel vaccine in 10-year-olds with results posted, evaluating safety and immunogenicity against tetanus, diph…
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination [Phase 3]
Phase 3 trial update reports antibody persistence at ages 3.5 and 4.5 years after primary and booster vaccination with DTaP-IPV-HepB-PRP~T o…
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age [Phase 4]
Phase 4 clinical trial update on Menactra in healthy infants at 9 months and co-administered with Pentacel at 15-18 months; results have bee…
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: Duration of Protection: GSK DTaP Vaccines
A completed clinical trial from GlaxoSmithKline evaluated the duration of protection provided by GSK's DTaP vaccine against diphtheria, teta…
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years Old [Phase 3]
Phase 3 trial comparing intramuscular SP306 to subcutaneous DT in Japanese adolescents aged 11-12 evaluating vaccines for tetanus, diphtheri…
-
CLINICAL_TRIALS trial_result · 2015-10-07Clinical Trial Update: Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED) [Phase 3]
Phase 3 trial of an investigational V441-001 vaccine in healthy infants in Taiwan has completed, targeting diphtheria, tetanus, pertussis, h…
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth [Phase 3]
Phase 3 trial of the DTaP-IPV-HepB-PRP-T pentavalent vaccine in Indian infants completed; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Database Surveillance Safety Study of PENTACEL® Vaccine
Completed database surveillance safety study evaluating the Pentacel vaccine for safety signals related to its diphtheria, tetanus, pertussi…
-
CLINICAL_TRIALS trial_result · 2015-07-22Clinical Trial Update: Study to Analyze the Risk Factors Associated With Pertussis/Whooping Cough Infection Among Infants
GlaxoSmithKline-sponsored trial examining risk factors for pertussis infection among infants has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age [Phase 3]
A Phase 3 trial evaluating the DTap-IPV vaccine as the fifth dose in children aged 4 to 6 years, comparing it with DAPTACEL and IPOL; result…
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216
Follow-up study reports antibody responses to hepatitis B, acellular pertussis toxin, and inactivated poliovirus antigens 1 month after the …
-
CLINICAL_TRIALS trial_result · 2015-05-19Clinical Trial Update: Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China. [Phase 3]
Phase 3 trial in China evaluating Sanofi Pasteur's Tdap booster vaccine against local diphtheria-tetanus vaccines in children and adolescent…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis [Phase 2]
Phase 2 trial of a combined tetanus, diphtheria, acellular pertussis, and inactivated poliomyelitis vaccine sponsored by Sanofi Pasteur has …